These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 20335433

  • 1. Staphylococcus aureus exotoxins are present in vivo in tampons.
    Schlievert PM, Nemeth KA, Davis CC, Peterson ML, Jones BE.
    Clin Vaccine Immunol; 2010 May; 17(5):722-7. PubMed ID: 20335433
    [Abstract] [Full Text] [Related]

  • 2. Impact of Currently Marketed Tampons and Menstrual Cups on Staphylococcus aureus Growth and Toxic Shock Syndrome Toxin 1 Production In Vitro.
    Nonfoux L, Chiaruzzi M, Badiou C, Baude J, Tristan A, Thioulouse J, Muller D, Prigent-Combaret C, Lina G.
    Appl Environ Microbiol; 2018 Jun 15; 84(12):. PubMed ID: 29678918
    [Abstract] [Full Text] [Related]

  • 3. Reduction in Staphylococcus aureus growth and exotoxin production and in vaginal interleukin 8 levels due to glycerol monolaurate in tampons.
    Strandberg KL, Peterson ML, Schaefers MM, Case LC, Pack MC, Chase DJ, Schlievert PM.
    Clin Infect Dis; 2009 Dec 01; 49(11):1711-7. PubMed ID: 19863450
    [Abstract] [Full Text] [Related]

  • 4. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM.
    Eur J Clin Microbiol Infect Dis; 2020 Jan 01; 39(1):31-38. PubMed ID: 31853743
    [Abstract] [Full Text] [Related]

  • 5. Vaginal Tampon Colonization by Staphylococcus aureus in Healthy Women.
    Chiaruzzi M, Barbry A, Muggeo A, Tristan A, Jacquemond I, Badiou C, Cluzeau L, Bourdeau S, Durand T, Engelmann A, Bosquet D, Bes M, Prigent-Combaret C, Thioulouse J, Muller D, Lina G.
    Appl Environ Microbiol; 2020 Sep 01; 86(18):. PubMed ID: 32680868
    [Abstract] [Full Text] [Related]

  • 6. Vaginal tampon model for toxic shock syndrome.
    Melish ME, Murata S, Fukunaga C, Frogner K, McKissick C.
    Rev Infect Dis; 1989 Sep 01; 11 Suppl 1():S238-46; discussion S246-7. PubMed ID: 2928642
    [Abstract] [Full Text] [Related]

  • 7. Device-Associated Menstrual Toxic Shock Syndrome.
    Schlievert PM, Davis CC.
    Clin Microbiol Rev; 2020 Jun 17; 33(3):. PubMed ID: 32461307
    [Abstract] [Full Text] [Related]

  • 8. Vaginal community state types (CSTs) alter environmental cues and production of the Staphylococcus aureus toxic shock syndrome toxin-1 (TSST-1).
    Maduta CS, McCormick JK, Dufresne K.
    J Bacteriol; 2024 Mar 21; 206(3):e0044723. PubMed ID: 38334326
    [Abstract] [Full Text] [Related]

  • 9. Staphylococcal Superantigens Stimulate Epithelial Cells through CD40 To Produce Chemokines.
    Schlievert PM, Cahill MP, Hostager BS, Brosnahan AJ, Klingelhutz AJ, Gourronc FA, Bishop GA, Leung DYM.
    mBio; 2019 Mar 19; 10(2):. PubMed ID: 30890614
    [Abstract] [Full Text] [Related]

  • 10. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method.
    Robbins RN, Reiser RF, Hehl GL, Bergdoll MS.
    J Clin Microbiol; 1987 Aug 19; 25(8):1446-9. PubMed ID: 3624442
    [Abstract] [Full Text] [Related]

  • 11. Complex ecological interactions of Staphylococcus aureus in tampons during menstruation.
    Jacquemond I, Muggeo A, Lamblin G, Tristan A, Gillet Y, Bolze PA, Bes M, Gustave CA, Rasigade JP, Golfier F, Ferry T, Dubost A, Abrouk D, Barreto S, Prigent-Combaret C, Thioulouse J, Lina G, Muller D.
    Sci Rep; 2018 Jul 02; 8(1):9942. PubMed ID: 29967393
    [Abstract] [Full Text] [Related]

  • 12. Glucose Mediates Niche-Specific Repression of Staphylococcus aureus Toxic Shock Syndrome Toxin-1 through the Activity of CcpA in the Vaginal Environment.
    Dufresne K, Podskalniy VA, Herfst CA, Lovell GFM, Lee IS, DeJong EN, McCormick JK, Tuffs SW.
    J Bacteriol; 2022 Oct 18; 204(10):e0026922. PubMed ID: 36106854
    [Abstract] [Full Text] [Related]

  • 13. [Cases of menstrual toxic shock syndrome in the Czech Republic in 1997-2011].
    Petrás P, Machová I, Rysková L, Prásil P.
    Epidemiol Mikrobiol Imunol; 2011 Nov 18; 60(4):161-6. PubMed ID: 22324245
    [Abstract] [Full Text] [Related]

  • 14. Discovery of an antivirulence compound that targets the Staphylococcus aureus SaeRS two-component system to inhibit toxic shock syndrome toxin-1 production.
    Dufresne K, DiMaggio DA, Maduta CS, Brinsmade SR, McCormick JK.
    J Biol Chem; 2024 Jul 18; 300(7):107455. PubMed ID: 38852884
    [Abstract] [Full Text] [Related]

  • 15. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC, Downs SA.
    J Clin Microbiol; 1989 Nov 18; 27(11):2482-7. PubMed ID: 2808672
    [Abstract] [Full Text] [Related]

  • 16. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
    Sharma H, Turner CE, Siggins MK, El-Bahrawy M, Pichon B, Kearns A, Sriskandan S.
    mSphere; 2019 Oct 09; 4(5):. PubMed ID: 31597722
    [Abstract] [Full Text] [Related]

  • 17. [Frequency of toxic-shock-syndrome-toxin producing strains of Staphylococcus aureus in the Basel region].
    Vischer WA, Stalder H, Faupel DM.
    Schweiz Med Wochenschr; 1985 Aug 31; 115(35):1196-9. PubMed ID: 4048915
    [Abstract] [Full Text] [Related]

  • 18. [Toxic shock syndrome toxin-1 producing strains of Staphylococcus aureus in vaginal smears].
    Dickgiesser N, Brombacher A, Wiest W.
    Geburtshilfe Frauenheilkd; 1987 Feb 31; 47(2):104-6. PubMed ID: 3569835
    [Abstract] [Full Text] [Related]

  • 19. Prevalence of toxic shock syndrome toxin 1-producing Staphylococcus aureus and the presence of antibodies to this superantigen in menstruating women.
    Parsonnet J, Hansmann MA, Delaney ML, Modern PA, Dubois AM, Wieland-Alter W, Wissemann KW, Wild JE, Jones MB, Seymour JL, Onderdonk AB.
    J Clin Microbiol; 2005 Sep 31; 43(9):4628-34. PubMed ID: 16145118
    [Abstract] [Full Text] [Related]

  • 20. Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome.
    De Boer ML, Kum WW, Chow AW.
    Can J Microbiol; 1999 Mar 31; 45(3):250-6. PubMed ID: 10408098
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.